ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Towards improving post-SSRI sexual dysfunction by using nutriceuticals: Lessons from a case study
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 134855" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">ABSTRACT </span></strong></p><p>Post-selective serotonin reuptake inhibitors (SSRIs) sexual dysfunction (PSSD) is a new </p><p>clinical entity occurring after the antidepressant intake, and it is characterized by the fact that </p><p>patients continue to present sexual side effects after the discontinuation of the drugs. PSSD mainly </p><p>consists of hypo-anesthesia of the genital area, loss of libido, and erectile dysfunction. Although </p><p>different management options have been proposed, there is no consensus on the treatment for this </p><p>syndrome. Herein we report on a young man affected by PSSD who regained sexual functioning </p><p>after 3-month treatment with EDOVIS, a dietary supplement containing L-citrulline and other </p><p>commonly used aphrodisiacs.</p><p></p><p>Clinicians should be aware about the possibility of persistent sexual side effects induced by </p><p>serotoninergic antidepressants and take into considerations the use of nutraceuticals to overcome PSSD.</p><p></p><p></p><p></p><p></p><p></p><p></p><p>In conclusion, clinicians should be aware about the possibility of persistent sexual side </p><p>effects induced by serotoninergic antidepressants and take into considerations the use of </p><p>nutraceuticals, with regard to EDOVIS, to overcome PSSD and the related problems in sexual </p><p>relationship and quality of life.</p></blockquote><p></p>
[QUOTE="madman, post: 134855, member: 13851"] [B][COLOR=rgb(184, 49, 47)]ABSTRACT [/COLOR][/B] Post-selective serotonin reuptake inhibitors (SSRIs) sexual dysfunction (PSSD) is a new clinical entity occurring after the antidepressant intake, and it is characterized by the fact that patients continue to present sexual side effects after the discontinuation of the drugs. PSSD mainly consists of hypo-anesthesia of the genital area, loss of libido, and erectile dysfunction. Although different management options have been proposed, there is no consensus on the treatment for this syndrome. Herein we report on a young man affected by PSSD who regained sexual functioning after 3-month treatment with EDOVIS, a dietary supplement containing L-citrulline and other commonly used aphrodisiacs. Clinicians should be aware about the possibility of persistent sexual side effects induced by serotoninergic antidepressants and take into considerations the use of nutraceuticals to overcome PSSD. In conclusion, clinicians should be aware about the possibility of persistent sexual side effects induced by serotoninergic antidepressants and take into considerations the use of nutraceuticals, with regard to EDOVIS, to overcome PSSD and the related problems in sexual relationship and quality of life. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Towards improving post-SSRI sexual dysfunction by using nutriceuticals: Lessons from a case study
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top